Testing effectiveness (Phase 2)WithdrawnNCT04334174
What this trial is testing
Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas
Who this might be right for
T Cell Lymphoma
University of Kansas Medical Center